Titlebook: Amorphous Drugs; Benefits and Challen Marzena Rams-Baron,Renata Jachowicz,Marian Paluch Book 2018 Springer International Publishing AG 2018

只看該作者 · 發(fā)表于 2025-3-24 02:36:17

Why Amorphous Drugs?,1, 2]. With the development of computational chemistry and high throughput screening methods it is possible to obtain a large number of compounds with attractive therapeutic activity. However, at the same time the selection of novel active molecules with suitable biopharmaceutical properties (like s

只看該作者 · 發(fā)表于 2025-3-24 06:52:16

只看該作者 · 發(fā)表于 2025-3-24 13:13:25

Amorphous Drug Solubility and Absorption Enhancement,rmaceutical technology. Over the last two decades the number of relatively insoluble drugs has grown steadily. Nowadays it is estimated that approximately 70% of new drug candidates are characterized by poor solubility. In order to ensure the optimum therapeutic efficacy, the selection of the drug s

只看該作者 · 發(fā)表于 2025-3-24 16:18:34

只看該作者 · 發(fā)表于 2025-3-24 19:28:29

只看該作者 · 發(fā)表于 2025-3-25 02:13:12

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-11-2 13:09
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved